Orion Corporation

Orion Oyj

Type	Julkinen osakeyhtiö
Traded as	OMX: ORNBV
Industry	Pharmaceutical industry
Founded	1917
Headquarters	Espoo, Finland
Key people	Timo Lappalainen (President and CEO), Hannu Syrjänen (Chairman)
Products	Pharmaceuticals, active pharmaceutical ingredients and diagnostic tests
Revenue	€849.9 million (2010)[1]
Operating income	€254.2 million (2010)[1]
Profit	€184.7 million (2010)[1]
Total assets	€745.8 million (end 2010)[1]
Total equity	€467.4 million (end 2010)[1]
Employees	3,140 (average, 2010)[1]
Website	www.orion.fi

Orion Corporation, founded in 1917 and headquartered at Espoo, Finland, is a Finnish company, which develops, manufactures and markets pharmaceuticals, active pharmaceutical ingredients and diagnostic tests for global markets. The company also has a large R&D unit in Turku.

Orion has annual net sales of approximately EUR 500 million; its class A and B shares are listed on the Helsinki Stock Exchange.

Products

This list is incomplete; you can help by expanding it.

Analgesics Indalgin (indometacin, ethylmorphine) Anti-diabetic drugs Glimepirid Orion (glimepiride) Metforem (metformin) Origlucon (glibenclamide) Gastric acid related drugs Ranimex (ranitidine) Zolt (lansoprazole) Oral hygiene Daktarin (miconazole) Elmex (olaflur) Motion sickness drugs Vertipam (cyclizine, diazepam and nicotinic acid) Vitamins Cohemin (cyanocobalamin) Neuramin (thiamine) Anticoagulants Marevan (warfarin) Cardiovascular drugs Digoxin (digoxin) Disomet (disopyramide) Dopmin (dopamine) Kiniduron (quinidine) Lidocard (lidocaine) Nitro (glyceryl trinitrate) Nitrosid (isosorbide dinitrate) Ormox (isosorbide mononitrate) Simdax (levosimendan) Antihypertensive drugs Amlodipin Orion (amlodipine) Carvedilol Orion Pharma (carvedilol) Dilzem (diltiazem) Escor (nilvadipine) Espesil (acebutolol) Lisipril (lisinopril) Lopril (captopril) Nifangin (nifedipine) Orloc (bisoprolol) Pinloc (pindolol) Pratsiol (prazosin) Propral (propranolol) Selopral (metoprolol) Verpamil (verapamil) Lisipril Comp (lisinopril and hydrochlorothiazide) Orloc Comp (bisoprolol and hydrochlorothiazide) Diuretics Diurex (hydrochlorothiazide and amiloride) Furesis (furosemide) Furesis Comp (furosemide and triamterene) Hydrex (hydrochlorothiazide) Indapamide Orion (indapamide) Spiresis (spironolactone) Uretren Comp (trichlormethiazide and triamterene) Hypolipidemic agents Atorvastatin Orion (atorvastatin) Lovacol (lovastatin) Pravastatin Orion (pravastatin) Simvastatin Orion (simvastatin)

References

1. ^ ^{a b c d e f} "Annual Results 2010". Orion. http://www.orion.fi/Documents/Osavuosikatsaukset/EN_Orion_FY2010.pdf. Retrieved 9 February 2011. 

External links

• Official website